期刊文献+

线粒体Prohibitin蛋白在紫杉醇耐药的CCRF-CEM细胞中表达的变化 被引量:2

Expression of mitochondrial prohibitin in paclitaxol-resistant CCRF-CEM cells
下载PDF
导出
摘要 目的:研究线粒体prohibitin蛋白在紫杉醇耐药的CCRF-CEM细胞中的表达变化,探讨线粒体prohib-itin蛋白在CCRF-CEM肿瘤细胞耐药发生机制中的作用。方法:提取紫杉醇耐药的CCRF-CEM/taxol细胞的线粒体总蛋白,对经双向电泳分离后得到的SDS-PAGE胶用ImageMasterTM2D Platinum software进行分析、比对,对胶上的蛋白点进行质谱分析,通过SWISS-PROT和NCBInr数据库鉴定蛋白的归属。结果:紫杉醇耐药的CCRF-CEM/taxol细胞中的线粒体prohibitin Protein15表达升高了68.6%(以蛋白表达的体积计)。结论:紫杉醇耐药的CCRF-CEM/taxol细胞中线粒体prohibitin表达增加。prohibitin可能通过调节线粒体的活动,对抗紫杉醇诱导的细胞凋亡,在耐药机制中发挥重要作用。 Objective: To elucidate the role of mitochondrial prohibitin in multi-drug resistant CCRF-CEM cells by determination of expression status of the prohibitin. Methods: The total mitochondrial proteins from CCRF-CEM cells or paclitaxol-resistant CCRF-CEM cells were extracted. The isolated proteins were separated by two-dimensional electrophoresis and then analyzed using ImageMasterTM 2D Platinum software. The protein spots on the gel were analyzed by MS and identified by comparison to SWISS-PROT database and NCBInr database. Results: One of the two mitochondrial prohibitins was overexpressed in CCRF-CEM/paclitaxol by 68.6% ( per protein volume expressed) compared with that in CCRF-CEM cells. Conclusion: The mitochondrial prohibitin may reduce multidrug resistances against the paclitaxol-induced CCRF-CEM cellular apoptosis by regulation of the mitochondria activities.
出处 《中国新药杂志》 CAS CSCD 北大核心 2007年第1期40-45,共6页 Chinese Journal of New Drugs
关键词 多药耐药 CCRF—CEM PROHIBITIN 线粒体蛋白质组 二维电泳 multi-drug resistance CCRF-CEM prohibitin mitochondrial proteomes two-dimensional electrophoresis
  • 相关文献

参考文献5

  • 1JOSHI B,KO D,ORDONEZ-ERCAN D,et al.A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis[J].Biochem Biophys Res Comm,2003,312(2):459 -466.
  • 2STEGLICH G,NEUPERT W,LANGER T.Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria[J].Mol Cell Biol,t999,19 (5):3435-3442.
  • 3NIJTMANS LG,DE JONG L,ARTAL-SANZ M,et al.Prohibitins act as amembrane-bound chaperone for the stabilization of mitochondrial proteins[J].EMBO J,2000,19 (11):2444-2451.
  • 4RAJALINGAM K,WUNDER C,BRINKMANN V,et al.Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration[J].Nat Cell Biol,2005,7(8):837 -843.
  • 5FUSARO G,WANG S,CHELLAPPAN S.Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis[J].Oncogene,2002,21 (29):4539-4548

同被引文献29

  • 1赵亮,丁彦青.比较蛋白质组学在肿瘤研究中的应用[J].国际肿瘤学杂志,2006,33(3):164-167. 被引量:2
  • 2邢晓明,王英红,黄琼,吕炳建,来茂德.应用蛋白质组学分析结直肠癌促泌素和糖调节蛋白78蛋白变化及其意义[J].中华病理学杂志,2007,36(2):107-112. 被引量:9
  • 3戴明,罗荣城.蛋白质组学在肺癌诊治研究中的应用[J].癌症,2007,26(6):669-672. 被引量:6
  • 4代智,周俭,李雪飞,刘银坤,樊嘉.人肝癌细胞转移相关蛋白膜联蛋白Ⅱ的筛查与分析[J].中华肝脏病杂志,2007,15(8):563-566. 被引量:5
  • 5Sonneveld P, de Ridder M, van der Lelie H, et al. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin’s lymphoma using CHOP versus CNOP chemotherapy[J]. J Clin Oncol, 1995, 13(10):2530-2539.
  • 6Maxwell SA, Mousavi-Fard S. Non-Hodgkin’s B-cell lymphoma: advances in molecular strategies targeting drug resistance[J]. Exp Biol Med (Maywood), 2013, 238(9):971-990.
  • 7Zhou TB, Qin YH. Signaling pathways of prohibitin and its role in diseases[J]. J Recept Signal Transduct Res, 2013, 33(1):28-36.
  • 8Tétreault N, De Guire V. miRNAs: Their discovery, biogenesis and mechanism of action [J]. Clin Biochem, 2013, 46(10-11):842-845.
  • 9Dong P, Jiang L, Liu J, et al. Induction of paclitaxel resistance by ERα mediated prohibitin mitochondrial-nuclear shuttling[J]. Plos One, 2013, 8(12): e83519.
  • 10Liu T, Tang H, Lang Y, et al. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin[J]. Cancer Lett, 2009, 273(2):233-242.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部